Celltex Therapeutics Corporation
2401 Fountain View Drive, Unit 416
Houston
Texas
77507
United States
Tel: 713-590-1000
Fax: 713-780-0866
Website: http://celltexbank.com/
Email: info@celltexbank.com
14 articles about Celltex Therapeutics Corporation
-
ANDREWS MEDICINE AND CELLTEX THERAPEUTICS CORPORATION JOIN FORCES TO BRING CUTTING EDGE TECHNOLOGIES TO ATHLETIC INJURIES
10/4/2022
James R. "Jim" Andrews , MD, Chairman and CEO of Andrews Medicine of Pensacola, Florida , and David G. Eller , Chairman and CEO of Celltex Therapeutics Corporation of Houston, Texas, announced today that together they will form a new biotechnology company to bridge the divide between stem cell research and the current treatment of athletic injuries.
-
Former U.S. Secretary of Energy and Texas Governor, Rick Perry, Names Two Texas Companies as Leading Innovators in the Fight Against COVID-19
7/14/2020
Celltex Therapeutics obtains approval from FDA to evaluate Celltex’s Mesenchymal Stem Cells as prevention against COVID-19 and Medistar Corporation’s biodefense HVAC filter to destroy nearly 100% of the virus
-
Celltex Therapeutics Receives Another FDA Approval: Phase II Clinical Trial Using Mesenchymal Stem Cells (MSCs) as a Prophylactic Against COVID-19
6/26/2020
Celltex, a Houston, Texas-based biotechnology company, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to proceed with the Company’s Investigational New Drug application (IND 22055) to investigate the Prophylactic Efficacy of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) Against Coronavirus Disease 2019 (COVID-19). This press release features multimedia. View
-
Celltex Plans to Launch Program to Use Mesenchymal Stem Cells for COVID-19-related Symptoms Under an Existing Regulatory Study
3/16/2020
Celltex Therapeutics Corporation (“Celltex”), a Houston, Texas-based biotechnology company founded in 2011 and focused on spearheading breakthroughs in regenerative medicine using adult, autologous Mesenchymal Stem Cells (“MSCs”), today announced that it has begun active discussions with the FDA regarding a study using MSCs against Coronavirus (“COVID-19”)-type symptoms. Celltex has researched safety and efficacy from the use o
-
Celltex Therapeutics Corporation Signs Memorandum of Understanding (MOU) with Saudi Arabia; Expands Presence to Riyadh - March 4, 2019
3/4/2019
Investment to support the commercialization of Celltex’s proprietary stem cell therapy technology
-
Celltex Therapeutics Corporation signs Memorandum of Understanding (MOU) with Saudi Arabia; expands presence to Riyadh
2/21/2019
Houston-based biotechnology company Celltex Therapeutics Corporation has entered a Memorandum of Understanding (MOU) with Saudi Arabia’s Research Products Development Company (RPDC) to support the commercialization of Celltex’s proprietary stem cell technology
-
Celltex autologous stem cell case study published by Gavin Publishers demonstrates potential cure for rheumatoid arthritis
11/8/2018
Dr. Jane Young contributes to peer-reviewed case study that follows the treatment of adult rheumatoid arthritis patient
-
Celltex Therapeutics to begin Wellness Protocol Clinical Trial in Mexico
2/27/2018
As trial sponsor, Celltex will provide adult autologous adipose tissue-derived mesenchymal stem cells (AdMSCs) cultured and expanded by Celltex's proprietary stem cell process, which yields adult autologous AdMSCs in quantities never possible for use in therapies for vascular, autoimmune, and degenerative diseases, as well as injuries.
-
Celltex Therapeutics Corporation Autologous Stem Cell Case Study Published In Stem Cells And Development Demonstrates Favorable Response In Pediatric Patients
3/13/2017
-
Celltex Therapeutics Corporation Release: Young Woman With Juvenile Arthritis And Dysautonomia Sees Major Improvements After Receiving Her Own Adult Stem Cells
9/23/2015
-
Celltex Therapeutics Corporation Release: Texas Woman Finds Answer For MS In Her Own Stem Cells
3/3/2015
-
Celltex Therapeutics Corporation Announces ‘Joint’ Partnership With Arthritis Foundation South Central Region
10/21/2014
-
Celltex Therapeutics Corporation to Initiate New Clinical Program as it Responds to FDA Letter
10/2/2012
-
Celltex Therapeutics Corporation Expands Laboratory Operations and Adds Depth to Its Management Team
8/3/2012